Close X
Friday, November 29, 2024
ADVT 
National

Canada signs agreement with AZ on COVID treatment

Darpan News Desk The Canadian Press, 23 Feb, 2022 03:23 PM
  • Canada signs agreement with AZ on COVID treatment

OTTAWA - The Canadian government has signed an agreement with pharmaceutical company AstraZeneca to procure 100,000 doses of a COVID-19 antibody therapy that's still under review by Health Canada.

A release from Public Services and Procurement Canada says the antibody therapy, called Evusheld, is a pre-exposure preventative for COVID-19.

Evusheld is under review by Health Canada for use in specific high-risk patient populations, such as people who are immunocompromised.

The U.S.-based Food and Drug Administration issued an emergency use authorization for the product in December.

The FDA says the drug is only authorized for people who are not currently infected with COVID-19 and who are either moderately to severely immunocompromised or have a history of severe adverse reactions to a COVID-19 vaccine.

The FDA says one dose of Evusheld, given as two separate intramuscular injections, "may be effective for pre-exposure prevention for six months."

Health Canada started the authorization process for Evusheld in November after receiving data from AstraZeneca. The agency says it reviews submissions through an independent process and authorizes products based on "scientific rigour and medical evidence."

Public Services and Procurement Canada says initial deliveries of Evusheld would be expected within a month of authorization.

The Public Health Agency of Canada would then coordinate distribution and delivery with provinces and territories.

Filomena Tassi, Canada's Minister of Public Services and Procurement, said in a release Wednesday that vaccines continue to be "the most important tool we have against severe outcomes from COVID-19."

"However, while vaccines provide excellent protection, people who are immunocompromised may need additional protection against COVID-19," she said.

"That is why our government continues to grow its suite of treatments and preventative therapies to protect the health of everyone who lives in Canada."

 

MORE National ARTICLES

B.C. Premier Horgan completes cancer treatment

B.C. Premier Horgan completes cancer treatment
Horgan posted the update on Twitter, saying he is "so grateful" for the compassion and professionalism of the BC Cancer team and health workers across the province who are under incredible strain right now.

B.C. Premier Horgan completes cancer treatment

Fish processing plant to close in Surrey, B.C.

Fish processing plant to close in Surrey, B.C.
Fisheries Minister Joyce Murray could not immediately be reached for comment but said last month she plans to ensure the decision to phase out 19 open-net pen farms from the Discovery Islands is carried on to completion.

Fish processing plant to close in Surrey, B.C.

Copy-cat fear after Texas synagogue hostage siege

Copy-cat fear after Texas synagogue hostage siege
Toronto police have also increased patrols around synagogues and other Jewish community buildings, although they have said there is no known threat at this time.

Copy-cat fear after Texas synagogue hostage siege

Winter storm pummels large stretch of Ontario

Winter storm pummels large stretch of Ontario
Environment Canada issued snowfall, winter storm or blizzard warnings for a stretch of the province spanning from the Cornwall area to the east, the Algonquin region to the west, and the Niagara and London regions to the south.

Winter storm pummels large stretch of Ontario

China Omicron claim on Canada 'ludicrous': expert

China Omicron claim on Canada 'ludicrous': expert
A Chinese state-controlled news outlet first reported that the Jan. 7 infection of a Beijing resident was the result of receiving a letter or parcel from Canada that passed through Hong Kong.

China Omicron claim on Canada 'ludicrous': expert

Health Canada approves Pfizer COVID-19 drug

Health Canada approves Pfizer COVID-19 drug
The agency authorized Paxlovid for adult patients with mild or moderate COVID-19 who are also at high risk of becoming more seriously ill. Health Canada did not authorize it for use on teenagers or on patients who are already hospitalized because of COVID-19

Health Canada approves Pfizer COVID-19 drug